Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
This guide explains how to identify price-weighted indexes and what characteristics indicate a price-based method.
25,721 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
CleanSpark led February bitcoin production among three miners, while Cango and BitFuFu together added more than 700 B...
BitMine announces a sizable addition to its Ethereum stash, buying about 61,000 ETH and boosting holdings to about 4....
AppLovin exposes investors to a volatile mix of ad spend cycles and AI disruption fears. This guide breaks down the d...
When doximity stock plunged today, the market focused on earnings quality and future profitability. This article brea...
A 68-year-old couple has relied on an 8% yield from a long-held closed-end fund for over a decade, sparking debate am...
Redwire stock swung sharply during today’s session, leaving investors with questions about its business model and gro...
The market has been pushing toward higher rates, and the phrase uh-oh! probability fomc rate is popping up in convers...
Grayscale argues that saylor’s strategy $1.5bb cashflow is being squeezed by a growing load of preferred-stock obliga...
If you’re itching to buy your first rental but dread the 20% down barrier, you’re not alone. This guide shares three ...
Mortgage rates sit above 6.6%, yet early 2026 data suggest the housing market still grow. This report breaks down wha...
Investors want to know if now is the time figma stock? This guide breaks down how to evaluate Figma stock, what metri...